Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. https://doi.org/10.1038/nrendo.2017.151.

Article  PubMed  Google Scholar 

Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. https://doi.org/10.1016/S0140-6736(14)61393-3.

Article  CAS  PubMed  Google Scholar 

Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G. Prospective cohort study of type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care. 2008;31(10):2003–5. https://doi.org/10.2337/dc08-0688.

Article  PubMed  PubMed Central  Google Scholar 

Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care. 2007;30(4):842–7. https://doi.org/10.2337/dc06-2011.

Article  PubMed  Google Scholar 

Xu Q, Park Y, Huang X, et al. Diabetes and risk of Parkinson’s disease. Diabetes Care. 2011;34(4):910–5. https://doi.org/10.2337/dc10-1922.

Article  PubMed  PubMed Central  Google Scholar 

Palacios N, Gao X, McCullough ML, et al. Obesity, diabetes, and risk of Parkinson’s disease. Mov Disord. 2011;26(12):2253–9. https://doi.org/10.1002/mds.23855.

Article  PubMed  PubMed Central  Google Scholar 

Simon KC, Chen H, Schwarzschild M, Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology. 2007;69(17):1688–95. https://doi.org/10.1212/01.wnl.0000271883.45010.8a.

Article  PubMed  Google Scholar 

Rhee SY, Han KD, Kwon H, et al. Association between Glycemic Status and the risk of Parkinson Disease: a Nationwide Population-Based study. Diabetes Care. 2020;43(9):2169–75. https://doi.org/10.2337/dc19-0760.

Article  PubMed  PubMed Central  Google Scholar 

Chung HS, Lee JS, Kim JA, et al. Fasting plasma glucose variability in midlife and risk of Parkinson’s disease: a nationwide population-based study. Diabetes Metab. 2021;47(3):101195. https://doi.org/10.1016/j.diabet.2020.08.006.

Article  CAS  PubMed  Google Scholar 

Chohan H, Senkevich K, Patel RK, et al. Type 2 diabetes as a determinant of Parkinson’s Disease Risk and Progression. Mov Disord. 2021;36(6):1420–9. https://doi.org/10.1002/mds.28551.

Article  PubMed  PubMed Central  Google Scholar 

Cullinane PW, de Pablo Fernandez E, Konig A, Outeiro TF, Jaunmuktane Z, Warner TT. Type 2 diabetes and Parkinson’s Disease: a focused review of current concepts. Mov Disord. 2023;38(2):162–77. https://doi.org/10.1002/mds.29298.

Article  PubMed  Google Scholar 

Nauck MA, Wefers J, Meier JJ. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol. 2021;9(8):525–44. https://doi.org/10.1016/S2213-8587(21)00113-3.

Article  CAS  PubMed  Google Scholar 

Kizza J, Lewington S, Mappin-Kasirer B, et al. Cardiovascular risk factors and Parkinson’s disease in 500,000 chinese adults. Ann Clin Transl Neurol. 2019;6(4):624–32. https://doi.org/10.1002/acn3.732.

Article  PubMed  PubMed Central  Google Scholar 

Giovannucci E, Stampfer MJ, Colditz GA, et al. A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol. 1993;137(5):502–11.

Article  CAS  PubMed  Google Scholar 

Cereda E, Barichella M, Pedrolli C, et al. Diabetes and risk of Parkinson’s disease: a systematic review and meta-analysis. Diabetes Care. 2011;34(12):2614–23. https://doi.org/10.2337/dc11-1584.

Article  PubMed  PubMed Central  Google Scholar 

Dickerman BA, Garcia-Albeniz X, Logan RW, Denaxas S, Hernan MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019;25(10):1601–6. https://doi.org/10.1038/s41591-019-0597-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–72. https://doi.org/10.1016/S1474-4422(16)30230-7.

Article  PubMed  Google Scholar